Health Research Grants

The FY24 TERP CTA is intended to support the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY24 TERP Program Goals and at least one of the FY24 TERP Topic Areas. Funding Opportunity Number: HT942524TERPCTA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $10.4M total program funding.

The FY24 TERP IIRA is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition associated with military-related toxic exposures. Research projects may focus on any phase of research from basic laboratory research through translational research, including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial. New Approach Methodologies may also be used. Funding Opportunity Number: HT942524TERPIIRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $3.2M total program funding.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by NSF CISE. Supports the development of transformative high-risk, high-reward advances in computer and information science, engineering, mathematics, statistics, behavioral and/or cognitive research to address pressing questions in the biomedical and public health communities.

Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.

The FY25 Toxic Exposures Research Program (TERP) Investigator-Initiated Research Award (IIRA) is intended to support studies that will make an important contribution toward research and/or patient care for diseases or conditions associated with military-related toxic exposures. Research projects may focus on any phase of research from basic laboratory research through translational research, including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial. New Approach Methodologies may also be used. Funding Opportunity Number: HT942525TERPIIRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $3.9M total program funding.

The Biomedical Catalyst – Industry-led R&D (Small Projects) is a grant from Innovate UK (part of UKRI) that funds the development of innovative solutions to health and healthcare challenges. The programme supports small-scale industry-led R&D projects and is open to both single applicants and collaborative teams. Eligible applicants are UK-registered micro, small, and medium-sized enterprises (SMEs). A total of up to £25 million is available across the competition, with applications closing on 10 December 2025. To lead or work alone on a project, organisations must hold UK SME status and register through the Innovation Funding Service.

Developing Agency, Identity and Belonging in Young People is sponsored by The Colorado Health Foundation. Provides support for programs that offer safe, welcoming spaces for youth (BIPOC, LGBTQIA2S+, etc.) to develop relationships, community connection, and resilience outside of school or home. Geographic focus: Colorado Focus areas: Thriving Young People, Health Equity, Social-Emotional Development

The Bicycle Helmet Initiative is a grant from the North Carolina Department of Transportation that funds organizations distributing free bicycle helmets to promote cyclist safety across the state. The program provides 25 to 100 helmets per recipient, valued at approximately $500 to $2,000. Eligible applicants include North Carolina government entities, nonprofits, schools, churches, and public health agencies committed to bicycle safety education and outreach. The most recent application deadline was February 20, 2026. This initiative supports the state's broader Safe Routes to School and pedestrian and bicycle safety goals by ensuring cost is not a barrier to helmet access for North Carolina communities.

Connected Healthy Lives Grant Cycle is a grant from the Humana Foundation that funds organizations advancing health equity through innovative programs addressing the social determinants of health. The Humana Foundation directs its grantmaking around four core commitment areas, with a Health Equity Innovation Fund supporting bold, transformative approaches. Grants range from $50,000 to $2,500,000, with single-year and multi-year proposals accepted. Applicants must establish an organizational profile and complete an eligibility check through the Humana Foundation's SmartSimple grant management portal before submitting a proposal.

Colorado Energy Efficiency Business Rebate Program is a grant from the Colorado Department of Public Health and Environment that funds energy efficiency upgrades for small businesses in eligible Colorado communities. The program provides rebates for improvements such as LED lighting installations and commercial refrigeration equipment replacement. Awards are available up to $10,000 per business. Initially available in Aurora and Commerce City, with potential expansion to additional communities. Eligible applicants are Colorado-based small businesses operating in participating communities whose projects focus on qualifying energy efficiency upgrades. The program deadline was March 1, 2026.

NSF 25-509: Emerging Mathematics in Biology (eMB) is a grant from NSF that funds integrative research projects applying innovative mathematical theories and techniques to significant biological questions. The program supports truly interdisciplinary work at the interface of mathematics, biology, and public health, encouraging novel use of mathematical tools to advance biological understanding and inform public health policy. Eligible applicants include accredited two- and four-year institutions of higher education with campuses in the United States. Full proposals are due March 1 annually, with total funding ranging from $2 million to $6 million across multiple awards.

Health Equity Scholars for Action is sponsored by Robert Wood Johnson Foundation. This program supports the career development and academic progress of faculty conducting health equity research, with a focus on addressing challenges faced by historically marginalized faculty and improving social, political, and economic conditions that support health and health equity. While targeting faculty, the broader mission aligns with promoting health equity for communities of color.

Mobile Health (mHealth): Technology and Outcomes in Low and Middle Income Countries is a grant from the Fogarty International Center at NIH that funds research on mobile health technologies and their outcomes in low and middle income countries. Administered as an R21/R33 Phased Innovation Award, this funding opportunity supports studies that leverage mHealth tools to address health challenges in resource-limited settings. Participating NIH components include FIC, NEI, NIBIB, NICHD, NIDCD, NIMH, and NCI. Applications must align with the mission of the participating institutes. The program accommodates clinical trial optional designs. Award amounts vary by application and institute. The deadline for the most recent cycle was March 20, 2026.

Postdoctoral Research Fellowship Program – Basic and Preclinical Science is a grant from the Charles A. King Trust that supports mid- to late-stage postdoctoral fellows and mentored clinician scientists conducting basic and preclinical biomedical research in Massachusetts. The program funds researchers at a critical career juncture, providing resources for independent scientific investigation. The 2026 Full Stage Application deadline was March 25, 2026, with invitations sent February 12, 2026. Eligible applicants must be senior postdoctoral researchers or mentored clinician scientists based at research institutions in Massachusetts.

Massachusetts Community Health and Healthy Aging Funds 2026 is sponsored by Massachusetts Department of Public Health / Health Resources in Action. This grant program focuses on disrupting barriers to health in Massachusetts communities by investing in organizations addressing the root causes of health inequities through policy, systems, and environmental change approaches.

The Evidence for AI in Health (EVAH) initiative is a $60 million joint investment by the Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust to support rigorous, country-led evaluations of AI health tools in low- and middle-income countries. Delivered in partnership with J-PAL and the African Population and Health Research Center, EVAH funds evaluations of AI-enabled clinical decision support tools in primary and community healthcare settings across Sub-Saharan Africa, South Asia, and Southeast Asia. Pathway A supports early-deployment evaluations focusing on usability, workflow integration, and safety for up to $1 million. Pathway B funds randomized controlled trials, economic analyses, and implementation science studies of tools ready for deployment at scale for up to $3 million. The initiative addresses a critical evidence gap about whether AI diagnostic and clinical decision support tools actually improve health outcomes in resource-limited settings.

Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NIAMS intends to publish a NOFO for research on ancillary studies that leverage resources from ongoing parent clinical studies (e.g., patient cohorts, infrastructure, data, biological samples). While parent studies can be outside the NIAMS mission, the ancillary study itself must align with the NIAMS mission.

NSF FDT-BioTech Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation is sponsored by National Science Foundation, National Institutes of Health, and Food and Drug Administration. The NSF FDT-BioTech program, a joint initiative of the National Science Foundation, National Institutes of Health, and the Food and Drug Administration, supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the …

Notice of Special Interest (NOSI): Encouraging Women's Health Research within the NIDCD Mission Areas is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / National Institutes of Health (NIH). This notice solicits grant applications seeking to improve women's health across the lifespan within the scope of NIDCD's mission.

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) is sponsored by U.S. Department of Health and Human Services; Office of Research on Women's Health; 3 more sponsors. This grant supports collaborative research to address Non-Communicable Disease (NCD) health disparities among Latin American and U. S. Hispanic/Latino populations, emphasizing innovative interventions and international partnerships.

The Trailblazer Award for New and Early Stage Investigators (R21) is a grant from the National Institutes of Health, administered by the National Institute of Biomedical Imaging and Bioengineering and partner ICs, that funds exploratory biomedical and bioengineering research led by new and early-stage investigators. The program encourages unconventional, high-risk and high-reward approaches in imaging, bioengineering, and health informatics. Eligible applicants must be new or early-stage investigators who have not previously served as principal investigator of an NIH R01 or equivalent award. Clinical trials are permitted under this mechanism.

The Wellcome Mental Health Data Prize UK 2026-2028 supports the development of data tools and AI solutions contributing to improving early intervention for anxiety, depression, and psychosis. This prize program, managed in partnership with Social Finance, funds teams to develop innovative data science and AI tools that can identify individuals at risk of mental health conditions earlier and connect them with appropriate interventions. The prize builds on Wellcome's broader mental health science priorities and complements their separate generative AI mental health research program. Previous rounds funded teams at approximately £200,000 each. The UK 2026 round accepts applications until May 8, 2026 at 12pm. The prize program has previously operated in Africa (2024-2026 with £200,000 per team) and globally (2022-2023 with £1.4 million total). Contact: dataprize@wellcome.org.

NOAA's Competitive Research Program: Harmful Algal Bloom Innovation Challenge — Toxin Detection in Seafood is a grant from the National Oceanic and Atmospheric Administration (NOAA) that funds research and development of innovative methods for detecting harmful algal bloom (HAB) toxins in seafood. The program addresses a critical public health and food safety challenge, supporting approaches that improve the speed, accuracy, or accessibility of toxin detection in commercially and recreationally harvested seafood products. Eligible applicants include U.S. institutions of higher education, non-profit organizations, state and local governments, tribal entities, U.S. territories, and for-profit organizations. The application deadline is May 14, 2026. Award amounts are not publicly specified in the source materials.

Massachusetts Urban Agriculture Program is a grant from the Massachusetts Department of Agricultural Resources (MDAR) that funds commercial projects to increase the production, processing, and marketing of produce in urban areas across the Commonwealth. Priority areas include soil management, land acquisition, farm equipment, marketing and distribution, green infrastructure, innovative growing technologies like aquaponics and vertical farming, and organic farming transitions. Projects must represent long-term capital investments and foster youth development, small business development, and job training. Eligible applicants include 501(c)(3) nonprofit organizations, public or nonprofit educational or public health institutions, and established urban farmers with more than three years of commercial urban farming experience. Recent awards ranged from $20,000 to $30,000. Backyard produce or livestock raised for personal consumption is not funded.

The Alcohol Research Education Programs (R25) is a grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) that funds research education activities for health professionals focused on alcohol and other substance use disorders. Co-sponsored by NIDA, the program aims to attract health professionals to research careers in alcohol and substance use, improve their understanding of evidence-based treatment, and enhance clinical training programs. Eligible applicants include higher education institutions, nonprofits, and state/local governments. Awards provide up to $250,000 per year. The application deadline is May 25, 2026. Clinical trials are not allowed under this funding mechanism.

LAUNCH Program is sponsored by National Institutes of Health (NIH). The LAUNCH program supports the training of future global health researchers by providing early career researchers in the U.S. an opportunity for immersion in the wide-ranging health conditions and challenges experienced in international low-resource settings and to partner with local health researchers.

The NEI uses UG1 cooperative agreement awards to support investigator-initiated large-scale clinical trials, human gene-transfer, stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring. For purposes of this Notice of Funding Opportunity (NOFO), the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders, or to compare the effectiveness of two or more established interventions. The NEI UG1-supported studies are typically funded as a group of single-component companion grant awards including the Chairs Grant, the Coordinating Center, and Resource Centers, when appropriate. Specifically, this NOFO encourages applications for the Chair's grant, which includes the scientific rationale, study aims and significance of the research project. Funding Opportunity Number: PAR-23-209. Assistance Listing: 93.867. Funding Instrument: CA. Category: HL.

NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed) is sponsored by National Library of Medicine (NIH). This funding opportunity supports the development of information resources and services that provide accurate health information to populations experiencing health disparities and their providers, to improve health literacy, decision-making, and reduce disparities.

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services; Office of Research Infrastructure Programs (United States); National Institutes of Health. This grant supports the development of broad-impact human health and disease models and resources for biomedical research, applicable across multiple NIH institutes.

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health, Office of Research Infrastructure Programs. This grant supports the development of broad-impact human health and disease models and resources for biomedical research, applicable across multiple NIH institutes.

The NIH Office of Research on Women's Health (ORWH) and participating NIH Institutes and Centers invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs". Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to the health of women and, where appropriate, the use of both sexes to better understand the influence of sex as a biological variable on health and disease. This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development. Funding Opportunity Number: RFA-OD-24-013. Assistance Listing: 93.121,93.273,93.279,93.313,93.398,93.846,93.855,93.866. Funding Instrument: G. Category: ED,HL. Award Amount: Up to $840K per award.

Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (NRSA) for Primary Medical Care (HRSA-26-036) is sponsored by Health Resources and Services Administration (HRSA). This program aims to develop a skilled research workforce to advance scientific knowledge in primary care by providing support for postdoctoral healthcare professionals who plan to pursue careers in biomedical and behavioral health research related to primary care.

Asthma Home Visit Collaborative (HVC) Grant Program is sponsored by Illinois Department of Public Health. This program aligns with the CDC's Controlling Childhood Asthma and Reducing Emergencies (CCARE) initiative and EXHALE Technical Package. It aims to improve childhood asthma outcomes and prevent hospitalizations and emergency department visits through in-person or virtual home visiting services and the implementation of evidence-based EXHALE strategies.

Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (RFA-EB-26-003) is sponsored by National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB). This Notice of Funding Opportunity (NOFO) solicits applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black College and Universities (HBCUs).

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) (PAR-25-342) is sponsored by National Institutes of Health (NIH). This funding opportunity supports innovative, collaborative, and interdisciplinary research focused on clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements that address health and healthcare disparities related to non-communicable and chronic diseases (NCDs) with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. While the title emphasizes NCDs, the broader theme of improving health outcomes and addressing disparities in Latin America can be relevant for global health and infectious disease research, especially where co-infections or social determinants of health play a role.

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) is sponsored by National Institutes of Health. Supports innovative research addressing health disparities related to non-communicable and chronic diseases in Latin America, aiming to improve health outcomes across the hemisphere.

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services; National Library of Medicine (NLM); National Institutes of Health. This NIH funding opportunity, with NLM participation, supports innovative, scalable bioinformatics research with broad biomedical impact. This could include developing computational tools and methods for analyzing and integrating exposome data using AI.

Research Project Grant (Parent R01 Clinical Trial Required) is sponsored by National Institute on Aging (NIA). This is a broad funding opportunity for research projects, and the NIA supports and conducts research to understand the nature of aging and extend healthy, active years of life, including research on age-related diseases and conditions.

Research Grants in Clinical Informatics (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health. This NIH funding opportunity supports innovative clinical informatics research to transform health data into actionable knowledge. AI and ML are often key components in advancing clinical informatics.

Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program (PA-26-085) is sponsored by NIH Fogarty International Center. This program funds collaborative health research projects between U.S. and Finnish universities. While not explicitly focused on traditional medicine or complementary health, research in global health could be part of the collaborative projects.

Research Grants in Clinical Informatics (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health (NIH). This NIH funding opportunity supports innovative clinical informatics research to transform health data into actionable knowledge. While broad, it can include projects leveraging AI for data analysis and integration to advance biomedical research.

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) is sponsored by U.S. Department of Health and Human Services; National Library of Medicine; National Institutes of Health (NIH). This program supports innovative, scalable bioinformatics research with broad biomedical impact. This can include AI applications within bioinformatics, translational bioinformatics, and computational biology.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI), National Institutes of Health (NIH). This funding opportunity invites investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically GLP-1 or dual GLP-1/GIP-1 receptor agonists, impact cancer risk. The focus includes reported effects on thyroid, prostate, and other cancer risks. The NOFO also aims to attract scientists from other fields to study incretin mimetic effects on cancer biology.

Grants Supporting Women's Health Research and Education Initiatives is sponsored by The Grant Portal (aggregator, but program likely real based on summary). Funding opportunity for nonprofit organizations, academic institutions, and healthcare or advocacy groups working in women's health and public health. This could potentially include studies on body composition in relation to women's health.

Innovative Mental Health Services Research Not Involving Clinical Trials (R01) is a grant from the National Institute of Mental Health (NIMH) that funds research investigating the effectiveness, implementation, and dissemination of mental health services outside of clinical trial settings. The program supports studies examining how mental health care is delivered, accessed, and experienced across diverse populations and settings. Eligible applicants include public and private higher education institutions, nonprofits, and research organizations in the United States and internationally. Award amounts vary based on project scope, with applications due June 5, 2026.

Great Plains Center for Agricultural Health Pilot/Feasibility Projects Academic Track is sponsored by Great Plains Center for Agricultural Health. Grants for academic/scientific investigators and those newly interested in agricultural safety and health research. Funding supports projects addressing occupational hazards relevant to farmers and farm workers in the Great Plains region, with a focus on work-related stress and mental health, prevention of slips, trips, and falls, equipment/tool safety, and chemical safety.

Watershed Rehabilitation Program (REHAB) is sponsored by USDA Natural Resources Conservation Service (NRCS). This program helps project sponsors rehabilitate aging dams that are reaching the end of their design life or no longer meet safety criteria. Rehabilitation efforts address public health and safety concerns and can also build or augment existing water supplies. Projects improve wildlife habitat, recreation, water quality, and supply.

Multimodal Digital Biomarkers Grant is sponsored by Labfront (supported by Zana). This joint grant funds researchers combining wearable-derived physiological data with voice biomarkers across two tracks: Cardiopulmonary Extension and Open Innovation (including mental health, sleep, occupational health, and neurological conditions). While not exclusively health equity AI, it strongly supports wearable technology and advanced data analysis for health insights, which can be applied to health equity research.

Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed) is sponsored by National Institute of Mental Health (NIMH). This funding opportunity supports the creation of standards for data and metadata from wearable devices and cell phones to promote re-use and integration of this data by researchers. The goal is to facilitate secondary data analysis and the development of software packages and workflows, which is crucial for advancing health equity research using wearable data. Applicants are expected to partner with device manufacturers and the research community.

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health; Office of Behavioral and Social Sciences Research. This funding opportunity promotes the rapid dissemination of validated neurotechnologies to the neuroscience community, supporting a wide range of organizations.

BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services; National Institutes of Health. BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24) is a grant from the National Institutes of Health that supports dissemination of resources for integration into neuroscience research practice.

Scholarships for Health Professions Students from Disadvantaged Backgrounds is sponsored by Health Resources and Services Administration (HRSA). This program promotes diversity among health professions students and practitioners by providing scholarships to students from disadvantaged backgrounds who have financial need and are enrolled, or accepted for enrollment, as full-time students at eligible health professions sch…

SNF Global Center Research Fellowship Program is sponsored by Stavros Niarchos Foundation Global Center for Child and Adolescent Mental Health at the Child Mind Institute. This competitive funding and career development initiative supports early-career researchers in low- and middle-income countries (LMICs) who are advancing child and adolescent mental health research. The program focuses on research that responds directly to local community needs and supports long-term research projects, training, mentorship, and international collaboration. Fellows will lead independent research projects as principal investigators.

Beckman Scholars Program is sponsored by Arnold and Mabel Beckman Foundation. The purpose of the Beckman Scholars Program is to help stimulate, encourage, and support research activities by talented, full-time undergraduate students who are pursuing their studies at accredited four-year colleges and universities located in the United States of America.

NIBIB Trailblazer Award for New and Early Stage Investigators (R21) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). This grant is for early-stage researchers to pursue projects at the intersection of engineering and the physical sciences with life sciences. It is ideal for high-risk, high-impact medical device research where preliminary data is not required.

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH. This funding opportunity supports early-stage dissemination and implementation (D&I) research projects in NIDCD mission areas, including hearing and balance. It aims to support projects that will set a foundation for a high-quality, D&I focused R01.

Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) is sponsored by National Institutes of Health (NIH). The NIH offers various funding opportunities for behavioral and social sciences research. While this specific R21 announcement title doesn't explicitly mention 'consumer behavior marketing science,' R21 grants support exploratory/developmental research, and consumer behavior aspects could be relevant within broader translational science, especially related to health behaviors. Researchers are encouraged to filter announcements by agency, topic, eligibility, or deadline on Grants.gov.

The Rural Health Transformation Program (RHTP) is a grant from the Missouri Department of Social Services (DSS) that funds systemic, long-term improvements to healthcare in rural communities across Missouri. Established by Public Law 119-21, this five-year, $50 billion federal investment addresses hospital closures, healthcare worker shortages, and poor health outcomes in rural areas. Missouri's DSS leads the state application alongside the Department of Health and Senior Services and Department of Mental Health. Funded activities span five strategic goals: prevention and chronic disease management, rural health network sustainability, healthcare workforce development, community health hubs, and healthcare technology adoption. Eligible applicants include rural healthcare organizations, hospitals, clinics, community-based organizations, local public health agencies, and other rural health providers in Missouri, with Hub Anchor applicants serving approximately 3–5 county regions. The total Missouri allocation is $216,276,817.66, with a deadline of June 18, 2026.

NCATS program (PAR-25-157) supporting development of innovative technologies for translational science including AI/ML-driven drug discovery, high-throughput screening automation, computational target identification, and novel assay platforms. Funds exploratory research that creates new tools, methods, and technologies to overcome specific translational bottlenecks in the drug development pipeline. Part of NCATS' broader mission that has enabled over 45 promising new drugs to move into clinical trials through partnerships with academia, industry, and patient advocacy groups. NCATS maintains a pharmaceutical collection of nearly every human-approved drug and automated solutions for rapid drug repurposing screening including for emerging infectious diseases.

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3, Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) (NCI also participating). This funding opportunity supports the development of biomarkers or clinical outcomes from digital health technology for remote monitoring in clinical trials.

Making a Difference in Real-World Bioethics Dilemmas Grants is sponsored by The Greenwall Foundation. This program supports research to help resolve important emerging or unanswered bioethics problems in clinical, biomedical, or public health decision-making, policy, or practice. Projects may be empirical, conceptual, or normative and aim for real-world, practical impact. While not exclusively AI-focused, AI ethics can be a relevant area within bioethics.

Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) is sponsored by U.S. Department of Health and Human Services, National Institutes of Health. This Notice of Funding Opportunity (NOFO) promotes innovative analysis and integration of NIH Common Fund data sets to advance biomedical research. AI and machine learning are frequently used for complex data analysis and integration.

CDC-RFA-JG-26-0058: Strengthening Public Health Laboratory Systems is sponsored by Centers for Disease Control and Prevention (CDC). This NOFO aims to protect and improve global public health by strengthening laboratory systems, improving the public health laboratory workforce, improving bio risk management, reinforcing emergency laboratory preparedness, enhancing laboratory quality management systems, and enhancing diagnostic capacity via rapid tests for low resource settings and genomic sequencing for pathogens of pandemic potential.

Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases (CDC-RFA-JG-26-0056) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) from the CDC aims to strengthen national capacity to prevent, detect, and respond to infectious disease threats through national partnerships. Activities will focus on improving public health laboratory systems, workforce, biorisk management, emergency laboratory preparedness, and enhancing diagnostic capacity via rapid tests for low-resource settings and genomic sequencing for pathogens of pandemic potential.

Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally (CDC-RFA-JG-26-0056) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) seeks to build upon activities funded by CDC to support Global Health Security (GHS) through implementation of programs and activities that focus on protecting and improving health globally through partnerships with Ministries of Health …

Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases is sponsored by Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). This cooperative agreement seeks to enhance the nation's ability to prevent, detect, and respond to infectious disease threats by supporting clinicians, healthcare professionals, healthcare systems, institutions, and organizations involved in patient care, public health, and inf…

Strengthening Public Health Surveillance Systems for Global Health Security is sponsored by Centers for Disease Control-GHC. This Notice of Funding Opportunity (NOFO) focuses on protecting and improving public health globally by strengthening public health surveillance systems, improving the surveillance workforce, enhancing the interface between disease surveillance and laboratory systems, reinforcin…

Global Health Security Partners' Surveillance Activities (CDC-RFA-JG-26-0113) is sponsored by Centers for Disease Control and Prevention (CDC). This Notice of Funding Opportunity (NOFO) supports global health security partners in developing or continuing surveillance activities to protect and improve public health globally. Activities include strengthening public health surveillance systems and workforce, improving the interface between surveillance and laboratory systems, reinforcing emergency surveillance preparedness, enhancing electronic disease surveillance platforms, and enhancing the use of surveillance data for public health action.

Strengthening Global Health Security by improving public health capacity to detect, notify, and respond to disease outbreaks globally (Estimated Post Date: April 24, 2026) is sponsored by Centers for Disease Control and Prevention-GHC. This Notice of Funding Opportunity (NOFO) is intended to support global health security partners in developing or continuing the implementation of surveillance activities.

Global Health Security: Strengthening Public Health Surveillance Systems is sponsored by Centers for Disease Control-GHC. This Notice of Funding Opportunity (NOFO) aims to protect and improve public health globally by strengthening public health surveillance systems, improving the public health surveillance workforce, enhancing electronic disease surveillance platforms, and reinforcing emergency surveillance preparedness. Activities will build and improve regional and country capacities to detect, respond, control, and prevent infectious diseases and emerging threats, including in developing countries and villages.

Cures Within Reach – Clinical Trials to Validate AI-Driven Drug Repurposing is sponsored by Cures Within Reach. This grant supports investigator-initiated, proof-of-concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved disease. The therapies supported by AI models must already be approved, and eligible trials must include AI-generated data as part of the preclinical support for the trial. This could be highly relevant for identifying existing drugs that AI suggests could be effective in colorectal cancer.

Peer Reviewed Cancer Research Program (PRCRP) is sponsored by U.S. Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). The PRCRP supports high-impact research across various cancer types, including colorectal cancer. It funds hypothesis-driven, innovative, and mature research projects, and clinical trials that address critical scientific or clinical cancer issues and have the potential for major near-term impact. The program emphasizes innovation and relevance to military health.

Huddle Up for Health Community Health Equity Grant is sponsored by CareFirst BlueCross BlueShield. Huddle Up for Health Community Health Equity Grant is a grant from CareFirst BlueCross BlueShield, in partnership with the Baltimore Ravens, that funds Maryland nonprofits building or enhancing programming focused on mental health support, awareness, and advocacy.

Huddle Up for Health Community Health Equity Grant is a grant from CareFirst BlueCross BlueShield, in partnership with the Baltimore Ravens, that funds Maryland nonprofits building or enhancing programming focused on mental health support, awareness, and advocacy. The program prioritizes organizations working in the behavioral health space that also address upstream social, economic, and environmental drivers of health. Eligible applicants are Maryland-based 501(c)(3) nonprofits. Awards are up to $50,000, with the application deadline on May 5, 2026. Now in its third year, the program reflects a long-standing collaboration between CareFirst and the Ravens to advance community wellness and reduce health disparities.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator is sponsored by Centers for Disease Control - NCCDPHP. This opportunity focuses on public health approaches to address Alzheimer's disease and related dementias, supporting initiatives like the National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerators.

Southern Illinois Healthcare Strategies is sponsored by Illinois Department of Public Health (IDPH). Funding supports the secondary prevention of individuals with a diagnosis of diabetes. IDPH will work with the grantee to improve screening reminders/prompts/alerts for complications related to diabetes, including diabetic retinopathy and chronic kidney disease within their electronic health record.

FY27 GLIA-CTN Career Development Award is sponsored by Rare Diseases Clinical Research Network (RDCRN) - GLIA-CTN. This is a mentored award designed to provide protected time for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. Argininosuccinic aciduria can have neurological implications, and gene therapy research that touches on neurological aspects or underlying metabolic pathways relevant to leukodystrophies could be a fit.

Community Clean Air Grant Program is sponsored by City of Boston Air Pollution Control Commission (APCC). This program funds nonprofit organizations for community-based projects that reduce, mitigate, or monitor air pollution in the City of Boston. It aims to improve air quality and reduce exposure risks while raising awareness for air pollution-related environmental and public health challenges, contributing to Boston's carbon neutrality goal by 2050. Projects should directly address air pollution through mitigation, abatement, monitoring, or utilizing local air quality data to educate the community.

Bio-Medical Instruments mini-grant is sponsored by Foundation for Neurofeedback and Neuromodulation Research. This grant specifically focuses on projects that contribute to the knowledge of basic processes involved in neuromodulation methods and technologies or understanding the clinical effects of neurofeedback or other neuromodulation methods. This directly aligns with biomedical devices for biofeedback.

Pediatric Cancer Research Foundation Translational Research Grants is sponsored by Pediatric Cancer Research Foundation (PCRF). This grant primarily funds new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers. It supports programs involving open, multi-institutional cancer clinical trials or consortia that implement new approaches to therapy.

Fiscal Year (FY) 2026 Expanding Nutrition Services (ENS) is sponsored by Health Resources and Services Administration (HRSA). This funding will support HRSA-funded health centers in expanding access to nutrition services and food-based interventions within primary care settings. The goal is to prevent and manage chronic diseases such as obesity, heart disease, and diabetes. Applicants must increase the number of nutrition services patients or visits.

BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. This BRAIN Initiative Notice of Funding Opportunity (NOFO) aims to support the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific …

Mallinckrodt Foundation Biomedical Early-stage Investigator Grants is a grant from the Edward Mallinckrodt, Jr. Foundation that funds early-career biomedical researchers at American academic institutions. The program provides startup support to help investigators advance projects to the point where R01 or other independent funding can be secured. Recipients receive $75,000 annually for up to three years (grants are not renewable). Eligible applicants are tenure-track faculty in their first through fourth year who hold an M.D. and/or Ph.D. degree and do not currently have R01 or equivalent independent funding. Institutions may submit one proposal per application session. The deadline is July 1, 2026.

NAA Research Grant Program is sponsored by National Aphasia Association. The National Aphasia Association (NAA) offers research grants, including the Outdrive Aphasia Primary Progressive Aphasia (PPA) Research Grant focusing on interventions, care models, and support for individuals and families with PPA, and the Davetrina Seles Gadson Health Equity Mini-Grants for projects addressing equity and inclusion in aphasia care.

Growing Rural Opportunities for Wellbeing (GROW) Grant Program is sponsored by Indiana Department of Health (IDOH) and Indiana Family and Social Services Administration (FSSA). This program provides competitive regional grants focused on improving health in Indiana's rural communities, addressing issues such as maternal and infant health, access to care, nutritious food availability, chronic disease prevention, and rural health workforce development.

The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This opportunity from the National Cancer Institute (NCI) is for the Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory. This is a cooperative agreement (U24) and does not allow clinical trials.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecasted CDC-RFA-DP-26-0227) is sponsored by Centers for Disease Control and Prevention (CDC). Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecasted CDC-RFA-DP-26-0227) is sponsored by Centers for Disease Control and …

Pilot and Feasibility Grants is sponsored by Pittsburgh Liver Research Center (PLRC). These grants fund new initiatives and/or support new investigators pursuing liver-related research that should lead to R01-type funding or other extramural support. They provide support for investigators to collect preliminary data and/or test a novel hypothesis, with preference given to projects utilizing PLRC Scientific Cores. Research on hepatic stellate cell liver fibrosis fits within the mission.

The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) is sponsored by National Cancer Institute (NCI). This opportunity from the National Cancer Institute (NCI) is for the Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations. This is a cooperative agreement (UM1) and requires a clinical trial.

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator (Forecast) is sponsored by Centers for Disease Control and Prevention (CDC). This forecasted opportunity promotes brain health, addresses cognitive impairment, and supports caregivers using evidence-based approaches.

Instrumentation Grant Program for Resource-Limited Institutions (RLI-S10) is a grant from the National Institutes of Health (NIH), administered by the National Institute of General Medical Sciences (NIGMS), that supports acquisition of modern scientific instruments for research and education at resource-limited institutions. Awards range from ,000 to ,000. Instruments may support basic, translational, clinical, or biomedically related behavioral science research and may also be used in upper-level and graduate courses. This program targets institutions with limited existing research infrastructure, helping to enhance their biomedical research and education capacity. The deadline for the current cycle is July 2, 2026.

Technology-Enabled Learning Collaborative Program (HRSA-26-053) is sponsored by Health Resources & Services Administration (HRSA), Office of the Administrator. This program supports initiatives utilizing telehealth technologies to serve underserved populations. While the primary focus is on technology-enabled learning and service delivery, projects exploring the impact of telehealth on health equity and access for Medicaid populations could potentially align. It supports the use of technology-enabled collaborative learning to improve retention of health care providers and increase access to health care services in rural and underserved areas and populations.

Native American Research Centers for Health (NARCH) is sponsored by Indian Health Service (IHS), National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), U.S. Department of Health and Human Services (HHS). This program offers grants for new or continued Native American Research Centers for Health, which support health-related research, research career enhancement, and research infrastructure enhancement activities to meet the health needs of American Indian/Alaska Native (AI/AN) communities nationwide.

MCH Leadership, Education, and Advancement in Undergraduate Pathways (LEAP) Training Program is sponsored by Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau. This program establishes pathway programs to expand the maternal and child health workforce. These programs aim to increase access to healthcare and public health services for maternal and child health populations, including in rural or other underserved communities.

Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID) - NIH. The TRACs program aims to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.

National Environmental Leaders in Asthma is sponsored by U.S. Environmental Protection Agency (EPA). This program recognizes exemplary programs and community leaders who serve as national models for community asthma care improvement, including those addressing environmental asthma triggers. While not a direct grant for funding, it provides recognition and showcases achievements.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awards (ARPA-H) is sponsored by Advanced Research Projects Agency for Health (ARPA-H). ARPA-H supports small businesses with funding opportunities for innovative health research and development projects through SBIR/STTR awards. These awards focus on transformative ideas in health. While broad, specific open topics change.

National Research Service Award in Primary Care Medicine is sponsored by Health Resources and Services Administration (HRSA). The purpose of this program is to train and provide support to postdoctoral health care professionals who are planning to pursue careers in biomedical and behavioral health research related to primary care. The program aims to develop a skilled research workforce to advance scientific knowledge in primary care. Under HRSA, the NRSA program provides support to train postdoctoral health care professionals who are planning to pursue careers in biomedical and behavioral health research related to primary care.

Maternal and Child Health Leadership, Education, and Advancement in Undergraduate Pathways (LEAP) Training Program is sponsored by Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau, U.S. Department of Health and Human Services. This grant establishes pathway programs to expand the maternal and child health workforce. These programs aim to increase access to healthcare and public health services for MCH populations, including those in rural communities.

Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID's Strategic Plan for Research to Develop a Valley fever Vaccine.